Amlodipine Besylate Tablet
Product Images NDC 68071-4251

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 68071-4251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4251 1

A prescription drug label for Amlodipine Besylate 5 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a package containing 120 tablets. It mentions the tablets are round, white to off-white, and debossed with '210' on one side. The label includes NDC 68071-4251-1 and cautions to keep out of reach of children and store at controlled temperature 68-77°F.*

FDA Label Image

Figure 2 (Amlodipine Fig)

A forest plot showing hazard ratios with 95% confidence intervals comparing Farxors Amlodipine versus Farxors Placebo across various patient subgroups. The subgroups include overall patients, age groups (<65 and >=65), gender, baseline sitting systolic blood pressure categories, baseline vessel disease type, baseline vessels with stenosis, and PCI stent status. The plot indicates comparative risk assessments for these groups with hazard ratios plotted along a horizontal axis from 0 to 2.*

FDA Label Image

Figure 1 (Amlodipine Gra)

A Kaplan-Meier survival curve chart comparing event rates over time (in months) between Amlodipine and Placebo groups. The graph shows event rate on the y-axis and time up to 24 months on the x-axis. Data includes P-value (0.003), hazard ratio (0.691), and a 95% confidence interval (0.54, 0.88). The number of subjects at risk is noted below the x-axis at various time points.*

FDA Label Image

Amlodipine-str-2 (Amlodipine Str 2)

Chemical structure of amlodipine besylate, illustrating the molecular layout with specific atoms and bonds forming the compound's characteristic features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.